Jefferies

Games Global Announces Filing of Registration Statement for Proposed Initial Public Offering

Retrieved on: 
水曜日, 4月 17, 2024
Entertainment, Technology, General Entertainment, Other Technology, Electronic Games, Casino, Gaming, Sale, Prospectus, Investment, Broadridge Financial Solutions, EEA, Macquarie Group, Jefferies, Barclays, Finance, Madison Avenue, Gross metropolitan product, Form, Jefferies Group, European Economic Area, GGL, Order, Financial services, Attention, Telephone, Person, Security (finance)

The timing of the offering, number of shares to be offered and the price range for the proposed offering have not yet been determined.

Key Points: 
  • The timing of the offering, number of shares to be offered and the price range for the proposed offering have not yet been determined.
  • Games Global has applied to list its ordinary shares on the New York Stock Exchange under the symbol "GGL".
  • J.P. Morgan, Jefferies and Macquarie Capital are acting as joint book-running managers for the proposed offering.
  • These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective.

APi Group Announces Pricing of Public Offering of Common Stock

Retrieved on: 
水曜日, 4月 17, 2024
Engineering, Security, HVAC, Technology, Manufacturing, Construction & Property, Building Systems, UBS, Sale, Prospectus, API, TEL, RBC Capital Markets, Security (finance), Jefferies, Barclays, Form S-3, Public expenditure, Form, BofA Securities, Citigroup, Attention

APi Group Corporation (NYSE: APG) (“APi” or the “Company”) announced the pricing of an underwritten public offering of 11,000,000 shares of common stock at a public offering price of $37.50 per share.

Key Points: 
  • APi Group Corporation (NYSE: APG) (“APi” or the “Company”) announced the pricing of an underwritten public offering of 11,000,000 shares of common stock at a public offering price of $37.50 per share.
  • The gross proceeds to APi from the offering are expected to be approximately $412,500,000 million before deducting underwriting discounts and commissions and offering expenses payable by APi.
  • APi has granted to the underwriters a 30-day option to purchase an additional 1,650,000 shares of its common stock.
  • All of the shares of common stock to be sold in the offering are to be sold by APi.

UL Solutions Announces Pricing of Upsized Initial Public Offering

Retrieved on: 
金曜日, 4月 12, 2024
Science, Software, Other Science, Consulting, Professional Services, Technology, Supply Chain Management, Retail, Bank of America, Sale, Prospectus, UL, J.P. Morgan & Co., UBS, Broadridge Financial Solutions, Engagement, Jefferies, J. P. Morgan, Form, Bookrunner, BofA Securities, Citigroup, Wells Fargo, Attention, Telephone, Security (finance)

UL Solutions Inc. (“UL Solutions”) today announced the pricing of its upsized initial public offering of 33,800,000 shares of its Class A common stock at a public offering price of $28.00 per share.

Key Points: 
  • UL Solutions Inc. (“UL Solutions”) today announced the pricing of its upsized initial public offering of 33,800,000 shares of its Class A common stock at a public offering price of $28.00 per share.
  • The offering consists entirely of secondary shares to be sold by UL Standards & Engagement, a nonprofit organization that is currently the sole stockholder of UL Solutions.
  • The underwriters will have a 30-day option to purchase up to an additional 5,070,000 shares of Class A common stock from UL Standards & Engagement.
  • UL Solutions is not offering any shares of its Class A common stock in the proposed offering and will not receive any proceeds from the proposed sale of the shares.

FarmTogether Welcomes David Gould as Managing Director, Head of Capital Formation

Retrieved on: 
木曜日, 4月 18, 2024
University, American studies, Jefferies, Cargill, Elliott Investment Management, Growth, Duke University, Capital formation, ESG, MBA, SAN

SAN FRANCISCO, April 18, 2024 /PRNewswire/ -- FarmTogether , a leading farmland investment firm providing creative capital solutions in real assets, is pleased to announce that David Gould has joined the firm as Managing Director, Head of Capital Formation.

Key Points: 
  • SAN FRANCISCO, April 18, 2024 /PRNewswire/ -- FarmTogether , a leading farmland investment firm providing creative capital solutions in real assets, is pleased to announce that David Gould has joined the firm as Managing Director, Head of Capital Formation.
  • In this newly created role, David will be responsible for FarmTogether's long-term capital formation strategy, leading the firm's client relations, business development, and product expansion.
  • "David comes to FarmTogether with a proven track record in creating and delivering client solutions to drive capital growth, demonstrated by more than $2.4 billion in capital raised.
  • Most recently, David led capital markets, investor relations, and ESG at AMERRA Capital Management.

EQS-News: Final offer price for DOUGLAS AG shares set at 26.00 euro per share

Retrieved on: 
水曜日, 4月 10, 2024
Deutsche Bank, Citigroup, RBI, Growth, Frankfurt Stock Exchange, Goldman Sachs, WKN, UBS, Intesa Sanpaolo, UniCredit, IPO, BNP Paribas, Investment, Jefferies, LBBW, CVC Capital Partners, DOU, Security (finance)

CVC Capital Partners and the Kreke family remain main indirect shareholders after the IPO and do not sell any shares at the IPO.

Key Points: 
  • CVC Capital Partners and the Kreke family remain main indirect shareholders after the IPO and do not sell any shares at the IPO.
  • The total offer size amounts to around 890 million euro with gross proceeds for DOUGLAS AG of around 850 million euro, which corresponds to a market capitalization of DOUGLAS AG of around 2.8 billion euro.
  • Sander van der Laan, CEO DOUGLAS Group, said: “The significant investor interest in the DOUGLAS Group underlines the exceptional work our team has accomplished in recent months.
  • The shares of DOUGLAS AG are expected to be trading on the regulated market (Prime Standard) of the Frankfurt Stock Exchange from March 21, 2024, on.

Acrivon Therapeutics Announces $130 Million Private Placement Financing

Retrieved on: 
火曜日, 4月 9, 2024
ACRV, Exchange, Health, Intelligence, Patient, Neoplasm, Paradigm, Research, AP3, Sale, Security (finance), Prospectus, Investment, Therapy, PIPE, Jefferies, Machine learning, Medicine

Acrivon anticipates the gross proceeds from the oversubscribed PIPE to be approximately $130 million, before deducting fees to the placement agent and other offering expenses payable by the company.

Key Points: 
  • Acrivon anticipates the gross proceeds from the oversubscribed PIPE to be approximately $130 million, before deducting fees to the placement agent and other offering expenses payable by the company.
  • The closing of the financing is expected to occur on April 11, 2024, subject to customary closing conditions.
  • “We are excited to announce this financing and thank our new and key existing investors who have shown their support for and confidence in Acrivon,” said Peter Blume-Jensen, M.D., Ph.D., chief executive officer, president, and founder of Acrivon Therapeutics.
  • Jefferies acted as the exclusive placement agent in the private placement.

Perspective Therapeutics to Participate at Upcoming April Investor Conferences

Retrieved on: 
月曜日, 4月 8, 2024
Jefferies, Cancer, Conference, CATX, Radiopharmaceutical

SEATTLE, April 08, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced it will participate in two investor conferences in April.

Key Points: 
  • SEATTLE, April 08, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced it will participate in two investor conferences in April.
  • Thijs Spoor, Chief Executive Officer, will be participating in a panel discussion titled Radiopharmaceuticals: Energizing Disruption in Therapeutics, at the Goldman Sachs Third Annual Healthruption Conference, on April 9, 2024 at 2:40 p.m.
  • Management will be available for one-on-one investor meetings at the conference.
  • A replay of the Jefferies presentation will be archived for 90 days and available through the Investors page on the Perspective website.

Marex Group plc Announces Filing of Registration Statement for Proposed Initial Public Offering

Retrieved on: 
火曜日, 3月 26, 2024
Attention, Seventh Avenue, Madison Avenue, Goldman Sachs, 4th floor, Form, Keefe, Bruyette & Woods, Marex, Sale, Prospectus, Broadridge Financial Solutions, Jefferies, Equity capital markets, Jefferies Group, Barclays, Cryptocurrency

NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- Marex Group (“Marex”), the diversified global financial services platform, today announces that it has publicly filed a registration statement on Form F-1 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of its ordinary shares.

Key Points: 
  • NEW YORK, March 26, 2024 (GLOBE NEWSWIRE) -- Marex Group (“Marex”), the diversified global financial services platform, today announces that it has publicly filed a registration statement on Form F-1 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of its ordinary shares.
  • The timing of the offering, number of shares to be offered and the price range for the proposed offering have not yet been determined.
  • Barclays, Goldman Sachs & Co. LLC, Jefferies, and Keefe, Bruyette & Woods, a Stifel Company, are acting as joint lead book-running managers for the proposed offering.
  • A registration statement relating to these securities has been filed with the SEC but has not yet become effective.

ARIS MINING ANNOUNCES APPOINTMENT OF RICHARD ORAZIETTI AS CFO AND OLIVER DACHSEL AS SVP, CAPITAL MARKETS

Retrieved on: 
月曜日, 4月 8, 2024
Growth, Gold, Metal, Controller, Senior, Jefferies, Capital market, TSX, Goldcorp, Treasury, ARIS, Cryptocurrency

VANCOUVER, BC, April 8, 2024 /PRNewswire/ - Aris Mining Corporation (Aris Mining or the Company) (TSX: ARIS) (NYSE-A: ARMN) announces the appointment of Richard Orazietti as Chief Financial Officer, effective May 16, 2024, and Oliver Dachsel as Senior Vice President, Capital Markets.

Key Points: 
  • VANCOUVER, BC, April 8, 2024 /PRNewswire/ - Aris Mining Corporation (Aris Mining or the Company) (TSX: ARIS) (NYSE-A: ARMN) announces the appointment of Richard Orazietti as Chief Financial Officer, effective May 16, 2024, and Oliver Dachsel as Senior Vice President, Capital Markets.
  • Neil Woodyer, CEO of Aris Mining, commented "I am delighted to introduce Oliver and Richard as valuable additions to Aris Mining's management team.
  • Richard brings experience in corporate development, financial planning and reporting within the gold mining sector, having been the Senior Vice President, Treasury and Controller of Goldcorp.
  • Oliver has deep industry connections and corporate finance expertise, having most recently served as a Managing Director on Jefferies' metals & mining investment banking team in New York.

Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement

Retrieved on: 
火曜日, 3月 19, 2024
SVB Securities, BofA Securities, Madison Avenue, Form, Telephone, Patient, SAN, Sale, Attention, Cancer, Security (finance), Therapy, OrbiMed, Jefferies, IPSC, State Street, Jefferies Group

The offering includes participation from new and existing institutional investors, including Adage Capital Partners LP., Boxer Capital, Deep Track Capital, OrbiMed, Suvretta Capital and a life-sciences focused investor.

Key Points: 
  • The offering includes participation from new and existing institutional investors, including Adage Capital Partners LP., Boxer Capital, Deep Track Capital, OrbiMed, Suvretta Capital and a life-sciences focused investor.
  • The gross proceeds from the underwritten offering and private placement are expected to be approximately $100.0 million before deducting underwriting discounts and commissions and other offering expenses.
  • BofA Securities, Jefferies, and Leerink Partners are acting as the joint bookrunning managers for the underwritten offering.
  • A final prospectus supplement relating to and describing the terms of the underwritten offering will be filed with the SEC and will be available on the SEC’s web site at www.sec.gov.